Back to search

Article

Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodies

2022-07-15

Abstract excerpt

Since the end of 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant outcompeted other variants and took over the world. After the emergence of original Omicron BA.1, Omicron BA.2 subvariant emerged and outcompeted BA.1. As of July 2022, some BA.2 subvariants, including BA.2.12.1, BA.4 and BA.5, emerged in multiple countries and begun outcompeting original BA.2. Moreover, a novel BA....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0314b2bf-ccf7-5a88-9967-5bb688753fc3
DOI
10.1101/2022.07.14.500041
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodiesDOI 10.1101/2022.07.14.500041
Select a neighboring publication to make it the new centre.